We previously examined patient characteristics in patients undergoing radical prostatectomy between 2012 and 2014, and found that 64.3% of those patients had increased PSA levels but no PCa symptoms, suggesting wide-spread PSA screening2. Here, KLK3 is linked to posterior cortical atrophy.